Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Drugs in Pipeline
6
Phase 3 Programs
3
Upcoming Catalysts
2
Next Catalyst
Sep 1, 2026
36w| Drug Name | Phase |
|---|---|
Teriflunomide | Phase 3 |
Placebo | Phase 3 |
Oral Placebo | Phase 3 |
Ublituximab | Phase 2 |
Umbralisib | Phase 2 |
Ibrutinib | Phase 2 |
2 upcoming, 0 past
Primary completion for Placebo trial (NCT05877963) in Relapsing Multiple Sclerosis
SourcePrimary completion for Ublituximab trial (NCT05877963) in Relapsing Multiple Sclerosis
Source